Introduction
Drug-induced cholestasis is a liver disorder that might be caused by interference of drugs with the hepatobiliary bile acid transporters. It is important to identify this interference early on in drug development. In this work, Positron Emission Tomography (PET)-imaging with a 18 F labeled bile acid analogue was introduced to detect disturbed hepatobiliary transport of bile acids. 
Results

Radiosynthesis of [
18 F]FCA was achieved in a moderate radiochemical yield (8.11 ± 1.94%; non-decay corrected; n = 10) and high radiochemical purity (>99%). FCA was transported by the basolateral bile acid uptake transporters NTCP, OATP1B1 and OATP1B3. For canalicular efflux, BSEP and MRP2 are the relevant bile acid transporters. [ 
Introduction
The production of bile is an important function of the liver. One of the primary constituents are bile acids: amphiphilic molecules synthesized by hepatocytes that play a vital role in digestion of lipids and uptake of fat-soluble vitamins [1] . Bile acids are excreted in the canals of Hering, stored in the gallbladder and excreted into the duodenum via the common bile duct. Bile acids are part of the enterohepatic recirculation and are reabsorbed from the small intestine into the portal vein and transported back to the hepatocytes, where uptake occurs primarily by the basolateral transport protein Na + -dependent Taurocholate Cotransporting Polypeptide (NTCP). However, the Organic Anion Transporting Polypeptide (OATP) is also capable of transporting bile acids into the hepatocyte. Hepatic efflux of bile acids towards the bile canaliculi is mediated mainly by the Bile Salt Export Pump (BSEP) and also by the Multidrug Resistance-associated Protein 2 (MRP2) [1] .
Drug-induced liver injury (DILI) is an acquired liver disorder responsible for a significant amount of hospitalizations and a prime cause of rejecting new drug candidates during drug development [2, 3] . A major part of DILI is represented by drug-induced cholestasis (DIC), which results from inhibition of the bile acid transporters by drugs, leading to a toxic accumulation of bile acids in the liver [4, 5] .
It is important to detect drug-induced cholestasis early on in drug development. In this regard, nuclear imaging is a powerful tool to investigate interference with the bile acid transporters on a molecular level [6] . Various [9] [10] [11] [12] [13] . However, in order to study bile acid transport and the corresponding disturbances, the desired tracer would be a radiolabeled bile acid, predominantly transported by NTCP, BSEP, and by OATP and MRP2 [14] .
The synthesis and in vivo evaluation of different 11 C labeled bile acid analogues such as [ 11 C]cholylsarcosine was described [15, 16] . Although the results are promising, the half-life of the 11 C-isotope can limit its use. Consequently, a 18 F labeled bile acid was developed and evaluated in vivo in mice by Jia et al. [17] . In this study the 18 F isotope was incorporated in the bile acid by modification of the carboxyl functional group. Due to this major structural modification however, questions were raised whether the transport mechanism of this tracer was still comparable to endogenous bile acids [18] . To our knowledge, none of these PET bile acid analogues has had its transport characterized in vitro.
Therefore, the aim of this work was to develop and evaluate a 18 F labeled bile acid with minor modifications on the endogenous bile acid structure. This tracer can represent endogenous bile acid transport and can be used as imaging probe for preclinical evaluation of drug interference with the hepatic bile acid transporters. In vitro assays were performed to determine the involved bile acid transporters for uptake in, -and efflux out of, the liver. As proof of this concept, imaging experiments in mice were performed with the hepatotoxic drugs rifampicin and bosentan. Rifampicin is a known inhibitor of human/rodent OATP/oatp and MRP2/mrp2 [9, 19, 20] ; bosentan of NTCP/ntcp, and BSEP/bsep [21] [22] [23] .
Materials and methods Chemicals
All chemicals were at least reagent grade and obtained from Sigma Aldrich (Bornem, Belgium). Cryptand-2.2.2. was purchased at Acros Organics (Geel, Belgium). Cholic acid methyl ester was acquired from TCI Europe (Zwijndrecht, Belgium). All solvents were obtained from Chemlab (Zedelgem, Belgium) and were at least of HPLC-grade. estradiol-17β-glucuronide were obtained from Perkin Elmer. Synthesis of the precursor for radiosynthesis, 3α-Mesyl-7α,12α-Diacetoxy-5β-Cholanic acid methyl ester (MsAcCAME), and general synthesis information can be found in the supplementary data (S1 File). . The solution was azeotropically evaporated to dryness under a gentle nitrogen flow at 100˚C, followed by two additional drying steps with 500 μL AcN.
Radiosynthesis
The precursor for radiosynthesis (Fig 1; 4 mg MsAcCAME dissolved in 200 μL anhydrous DMSO) was added to the vial. The reaction mixture was heated for 20 minutes at 120˚C. Radiofluorination of precursor molecule MsAcCAME was monitored by TLC (10 mM NH 4 Ac:AcN 1:4 v:v). The vial was subsequently cooled to room temperature and NaOH (100 μL 3 M) was added to allow deprotection of the labeled intermediate [ Evaluation of a 18 as mobile phase; radiodetection (Ludlum Measurements Inc)). The desired HPLC-fraction was collected, diluted with ultrapure water and loaded onto a Sep-Pak C18 cartridge (preconditioned with 5 mL EtOH and 5 mL ultrapure water). The cartridge was washed with 5 mL ultrapure water and eluted with 500 μL EtOH. The solvent was evaporated under a gentle nitrogen flow and [ 
In vitro characterization
Cell culture. Transport of 3β-fluorocholic acid by NTCP, OATP1B1 and OATP1B3 was assessed using stable transfected cell lines. Chinese hamster ovary (CHO) cells, Human Embryonic Kidney (HEK), HEK293-OATP1B3 cells were purchased from Solvo Biotechnologies; CHO-NTCP and HEK293-OATP1B1 cells were a kind gift from the same company. CHO cells were cultured in Dulbecco's modified Eagle's medium (DMEM)/F12 with 10% fetal calf serum, 0.3 mM L-proline, 2 mM glutamine and penicilline/streptomycine (50 U/mL). HEK cells expressing OATP1B1, OATP1B3 and control cell lines were cultured in DMEM glutamax (high glucose/pyruvate) with 10% fetal calf serum, MEM non-essential amino acid supplement and penicilline/streptomycine (50 U/mL). All cell lines were cultured in a 37˚C 5% CO 2 environment.
In vitro uptake assay. Primary mouse hepatocytes were isolated as described previously [24] , formulated in DMEM medium at 1 million cells/mL and immediately incubated with 37 MBq [ At the indicated timepoints, 100 μL serum or hepatocyte incubation medium was withdrawn and 100 μL AcN was added. Samples were then centrifuged at 13000 g for 5 minutes and the supernatant was analyzed by the same semi-preparative RP-HPLC method as for the radiosynthesis of [ PET-data were obtained in list-mode and were iteratively reconstructed (50 iterations) in frames of 15 seconds for the first 10 minutes, followed by 50 frames of 1 minute. ROI's were drawn manually over liver, gallbladder and intestines using PMod software. A ROI was drawn in the left ventricle on the static [ 18 F]FDG scan to obtain an image-derived arterial blood input curve [25] . The uptake of [ 18 F]FCA in arterial blood, liver, gallbladder and intestines was expressed as a % injected dose (% ID) and normalized for the weight of a 20 gram mouse. Time-activity curves (TAC's) were generated using these values.
AUC, maximum % ID, and time to peak values were determined for the TAC's with Graphpad Prism v3.00. Differences between 2 groups were determined with the non-parametric Mann-Whitney U test. P-values 0.05 were considered significant. 
Results
Radiosynthesis
In vitro uptake
To determine the transport characteristics of 3β-fluorocholic acid, a competition experiment with (Fig 2) . IC50 values for this competition assay were 6.6 ± 0.8 μM for NTCP; 10.5 ± 1.1 μM for OATP1B1 and 25.2 ± 12.7 μM for OATP1B3. (Fig 3) . IC50 values of this inhibition were 252.6 ± 76.0 μM for BSEP and 577.2 ± 300.2 μM for MRP2.
In vitro efflux
In vitro investigation of [ Table 1 ). No uptake was observed in the urinary bladder or other organs.
The hepatobiliary transport of [ Table 2 . Rifampicin and bosentan treated mice showed an altered distribution of [ 18 F]FCA compared to control animals: time to peak of the liver TAC significantly increased 2.9 and 1.7-fold versus control for rifampicin and bosentan respectively. The maximum % ID in the liver was also significantly lower than control for both compounds (49.7 ± 1.6% and 54.4 ± 1.7% for rifampicin and bosentan respectively, compared Evaluation of a 18 to 71.2 ± 3.5% for control). Efflux towards the gallbladder and intestines was impaired: the AUC-value of the gallbladder & intestines TAC was 3.1 times lower than control for rifampicin and 1.7 times lower for bosentan. The AUC of the arterial blood TAC was 2.1-fold and 2.5-fold higher than control for rifampicin and bosentan respectively (see Fig 7) . Evaluation of a
Discussion
Bile acids are amphiphilic steroid derivatives that play a vital role in the digestion of lipids and uptake of fat-soluble vitamins. In many species, including rodents and humans, cholic acid makes up the larger part of the bile acid spectrum [26] . Cholic acid is therefore an opportune target to radiolabel and use as an imaging probe for hepatobiliary transport of bile acids in mice and humans alike. F PET-tracer shows remarkable structural resemblance to cholic acid, differing only in substitution of the 3α-OH with a 3β-fluorine. It was hypothesized that this modification would not have a major effect on transport by the bile acid transporters, as fluorine is isosteric and iso-electronic with a OHgroup. Moreover, the 3α-OH group is not an absolute requisite for active bile acid transport [27, 28] .
The radiofluorination of MsAcCAME with [ 18 F]fluoride showed an incorporation yield of 30%, which is in line with radiofluorination of a secondary mesylate directly attached to a cyclohexane ring [29] . This moderate yield can be attributed to the sterically hindered environment of the leaving group. After purification and formulation of [ [30] .
In vitro transport evaluation of [ 18 F]FCA revealed that the hepatic bile acid transporters involved in uptake and efflux are NTCP, OATP1B1, OATP1B3, BSEP and MRP2, which is also the case for endogenous bile acids [1, 31, 32] . Substitution of the 3α-OH of cholic acid with a 3β-fluorine did not have an effect on the ability to be transported by the same hepatobiliary transporters as endogenous bile acids.
The in vivo evaluation of [ Tc-mebrofenin in FVB-mice (2.2 minutes to reach 51.8 maximum % ID) [33] , uptake into the liver is slightly slower and reaches a comparable % ID. This behavior is similar to 11 C labeled bile acid analogues which also show a fast and exclusive hepatic uptake (<7 minutes), in pigs [15, 16] . On the other hand, Tc CA reach a lower peak value in the liver at reduced rate (12.7 minutes to reach 37.3 max % ID and 12.0 minutes to reach 25.7 max % ID respectively) [8] . Following rapid uptake into the liver, [ 18 F]FCA is excreted into the bile ducts, gallbladder and finally accumulates in the intestines. There was no accumulation of tracer visible in other organs for up to 6 hours post-injection. After 1 hour, activity in the gallbladder and intestines reached a Tc bile acids show a lower uptake into the liver and a lower accumulation in gallbladder and intestines.
[
18 F]FCA was developed to detect disturbed hepatobiliary transport of bile acids. As proof of concept, the oatp and mrp2 inhibitor rifampicin and the ntcp and bsep inhibitor bosentan were administered to FVB-mice and subjected to a PET-scan with [ 18 F]FCA. Both rifampicin and bosentan caused a significant delay in hepatic uptake and lower maximum % ID in the liver and both drugs gave rise to an increased amount of [ 18 F]FCA in arterial blood, which is in line with an observed increase in serum bile acids after administration of these drugs [19, 22] . When an identical dose of rifampicin was administered to FVB-mice scanned with 99m Tc mebrofenin [33] , a complete block of canalicular efflux was observed on the SPECTscan, whereas [ Tc mebrofenin transport, as this tracer is an exclusive oatp and mrp2 substrate [7] . 
